|
|
Volumn 3, Issue 2, 1999, Pages 61-63
|
|
Drug development output from 1975 to 1996: What proportion for tropical diseases?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALBENDAZOLE;
AMPHOTERICIN B LIPID COMPLEX;
ANTHELMINTIC AGENT;
ANTILEISHMANIAL AGENT;
ANTIMALARIAL AGENT;
ANTISCHISTOSOMAL AGENT;
ANTITRYPANOSOMAL AGENT;
ARTEETHER;
ARTELINIC ACID;
ARTEMETHER;
ARTEMETHER PLUS BENFLUMETOL;
ARTESUNATE;
ATOVAQUONE;
ATOVAQUONE PLUS PROGUANIL;
BENZNIDAZOLE;
CHLORPROGUANIL;
DAPSONE;
EFLORNITHINE;
ETAQUINE;
HALOFANTRINE;
IVERMECTIN;
MEFLOQUINE;
MILTEFOSINE;
NIFURTIMOX;
OXAMNIQUINE;
PAROMOMYCIN;
PENTAMIDINE ISETHIONATE;
PRAZIQUANTEL;
PYRONARIDINE;
SITAMAQUINE;
UNCLASSIFIED DRUG;
AFRICAN TRYPANOSOMIASIS;
CHAGAS DISEASE;
DRUG COST;
DRUG DEVELOPMENT;
DRUG RESEARCH;
EDITORIAL;
HELMINTHIASIS;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
LEISHMANIASIS;
MALARIA;
ONCHOCERCIASIS;
RECTAL DRUG ADMINISTRATION;
SCHISTOSOMIASIS;
TROPICAL DISEASE;
|
|
EID: 0032441598
PISSN: 12019712
EISSN: None
Source Type: Journal
DOI: 10.1016/S1201-9712(99)90010-3 Document Type: Editorial |
|
Times cited : (65)
|
|
References (5)
|
